Nathalie Horowicz-Mehler

Global Head of Value

Nathalie brings more than 25 years of experience in health economics and real-world evidence to Cytel’s Evidence, Value and Access business. She has a proven track record of driving growth by leading teams of scientist entrepreneurs and applies her clinical expertise as an epidemiologist and experience with HEOR, RWE/RWD and advanced analytics to catalyze innovations in public health.

Nathalie has held leadership roles at IQVIA, Concert AI, and Exponent. As Senior Vice President GM at ConcertAI, she leveraged her expertise to successfully establish their health economics and epidemiology practice. Most recently, she served as Principal Scientist at Exponent, focusing on pharmaceutical sector advancements and healthcare innovation.

Nathalie has an MS from Tufts University School of Medicine, and both an MPH and PhD from Columbia University Mailman School of Public Health.

Nathalie Horowicz-Mehler

Related Articles

Generative AI in Evidence Synthesis: Harnessing Potential with Responsibility
Blog
October 21, 2025
Generative AI in Evidence Synthesis: Harnessing Potential with Responsibility
Read More
Patient Centricity in Comparative Effectiveness Research
Blog
May 1, 2025
Patient Centricity in Comparative Effectiveness Research
Read More